MarketInOut Stock Screener Log In | Sign Up
 

IceCure Medical Ltd

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
IceCure Medical Ltd stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4.68 mln
Float1.52 mln
Earnings Date11/25/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-0.74
Highly suspicious

Relative Strength

28 / 100
Underperforming

Debt / Equity

0.01
Debt-free

Pre-Tax Margin

-428%
Severely loss-making

ROE

-203
Deeply negative

Business Description

IceCure Medical is an Israel-based company that develops and sells medical systems designed to destroy tumors by freezing them, a technique known as cryoablation. Its products are used across a wide range of medical fields, including breast cancer treatment, urology, and gynecology, and are available in markets such as the United States, Japan, China, and India. The company supplies hospitals, clinics, and surgical centers with both its core devices and the single-use accessories that accompany them. Founded in 2006, IceCure continues to expand its product range to address larger and more complex tumors.

Key Fundamentals

EPS-6.84
ROE-203
RPS1.56
ROIC-291
ROA-120
Interest Cover-140
EBITDA, mln-16.44
EV / EBITDA0.39
EV / EBIT0.38
Revenue, mln3.95

Quote Details

Last 1.01
Change 0.01 (1%)
Open 1.02
Volume 41,267
Turnover 41,680
Average Volume 184,583

Financial Ratios

Pre-Tax Profit Margin-428
Leverage Ratio1.49
Current Ratio2.88
Price / Book0.47
Price / Tangible Book0.47
Debt / Equity0.01
Price / Sales1.04

Financial Strength

Altman Z-Score-11.81
Piotroski F-Score 4 / 9
Beneish M-Score-0.74
Short Ratio0.47
Short % of Float1.48

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.72% 18 / 100   
1 Month -41.62% 6 / 100   
2 Months -69.67% 4 / 100   
6 Months -87.98% 2 / 100   
1 Year -95.76% 3 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog